Allegro MicroSystems Files 8-K for Disclosure and Exhibits

TL;DR

Allegro MicroSystems filed an 8-K for standard disclosures and exhibits, no major news.

AI Summary

On January 9, 2025, Allegro MicroSystems, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the filing of Financial Statements and Exhibits. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing indicates routine corporate reporting, ensuring transparency and compliance with SEC regulations regarding disclosures and financial statements.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report for disclosures and exhibits, not indicating any immediate material changes or risks.

Key Players & Entities

• Allegro MicroSystems, Inc. (company) — Registrant
• January 9, 2025 (date) — Date of earliest event reported
• 955 Perimeter Road, Manchester, New Hampshire 03103 (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — ch registered Common Stock, par value $0.01 per share ALGM The Nasdaq Stock Mar
• $375 million — Company") completed the allocation of a $375 million U.S. dollar-denominated first lien term

Filing Documents

• algm-20250109.htm (8-K) — 51KB
• 0000950170-25-003826.txt ( ) — 161KB
• algm-20250109.xsd (EX-101.SCH) — 25KB
• algm-20250109_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 9, 2025, Allegro MicroSystems, Inc. (the "Company") completed the allocation of a $375 million U.S. dollar-denominated first lien term facility maturing in October 2030 (the "Refinancing and Repricing Facility"). The applicable interest rate margin for term loans is expected to be (i) 2.0% for term loans bearing interest at a rate based on the secured overnight financing rate and (ii) 1.0% for term loans bearing interest at the base rate. The Company intends to use the proceeds of the Refinancing and Repricing Facility at closing to refinance in full the Company's existing term loans. The final terms of the potential refinancing and the Refinancing and Repricing Facility will be disclosed upon the completion of the transaction. The foregoing transactions are subject to customary conditions and are expected to close in February 2025. However, there can be no assurance that the Company will be able to successfully complete the transaction on the terms described above, or at all. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act, and Section 21E of the Exchange Act. All statements, other than statements of historical facts, contained in this Current Report on Form 8-K, including statements regarding the Refinancing and Repricing Facility, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as "aim," "may," "will," "should," "expect," "exploring," "plan," "anticipate," "could," "intend," "target," "project," "would," "contemplate," "believe," "estimate," "predict," "potential," "seek," or "continue" or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements. Forward-looking statements are based on our management's current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description Exhibit 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLEGRO MICROSYSTEMS, INC. Date: January 10, 2025 By: /s/ Derek P. D'Antilio Derek P. D'Antilio Executive Vice President, Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR